ARCOSA INC (ACA) Stock Fundamental Analysis
USA - NYSE:ACA - US0396531008 - Common Stock
102.094 USD
+2.68 (+2.7%)
Taking everything into account, ACA scores 5 out of 10 in our fundamental rating. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has an average financial health and profitability rating. ACA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
ACA had positive earnings in the past year.
In the past year ACA had a positive cash flow from operations.
In the past 5 years ACA has always been profitable.
ACA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ACA's Return On Assets of 2.94% is in line compared to the rest of the industry. ACA outperforms 52.73% of its industry peers.
ACA has a Return On Equity (5.75%) which is in line with its industry peers.
ACA's Return On Invested Capital of 4.99% is in line compared to the rest of the industry. ACA outperforms 45.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 16.87%.
The 3 year average ROIC (3.99%) for ACA is below the current ROIC(4.99%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
ACA has a Profit Margin of 5.25%. This is in the better half of the industry: ACA outperforms 67.27% of its industry peers.
In the last couple of years the Profit Margin of ACA has declined.
With a decent Operating Margin value of 10.27%, ACA is doing good in the industry, outperforming 74.55% of the companies in the same industry.
ACA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
ACA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACA has more shares outstanding
Compared to 5 years ago, ACA has more shares outstanding
ACA has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.33 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.33, ACA is in line with its industry, outperforming 45.45% of the companies in the same industry.
ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
ACA has a Debt to FCF ratio of 5.03. This is in the better half of the industry: ACA outperforms 61.82% of its industry peers.
ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, ACA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.33 |
ROIC/WACC0.51
WACC9.8%
2.3 Liquidity
ACA has a Current Ratio of 2.02. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.02, ACA belongs to the best of the industry, outperforming 89.09% of the companies in the same industry.
A Quick Ratio of 1.30 indicates that ACA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.30, ACA is in line with its industry, outperforming 58.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.03%, which is quite good.
Measured over the past 5 years, ACA shows a small growth in Earnings Per Share. The EPS has been growing by 5.16% on average per year.
ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.96%.
The Revenue has been growing by 8.15% on average over the past years. This is quite good.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
Based on estimates for the next years, ACA will show a very strong growth in Earnings Per Share. The EPS will grow by 20.31% on average per year.
Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 7.30% on average per year.
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.01, ACA can be considered very expensive at the moment.
ACA's Price/Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 67.27% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.07. ACA is around the same levels.
The Price/Forward Earnings ratio is 21.74, which indicates a rather expensive current valuation of ACA.
69.09% of the companies in the same industry are more expensive than ACA, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (34.08), we can say ACA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.01 | ||
| Fwd PE | 21.74 |
4.2 Price Multiples
ACA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACA is cheaper than 83.64% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACA indicates a rather cheap valuation: ACA is cheaper than 81.82% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.91 | ||
| EV/EBITDA | 12.06 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACA's earnings are expected to grow with 20.31% in the coming years.
PEG (NY)0.75
PEG (5Y)5.23
EPS Next 2Y24.91%
EPS Next 3Y20.31%
5. Dividend
5.1 Amount
ACA has a yearly dividend return of 0.20%, which is pretty low.
Compared to an average industry Dividend Yield of 1.79, ACA pays a better dividend. On top of this ACA pays more dividend than 81.82% of the companies listed in the same industry.
With a Dividend Yield of 0.20, ACA pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
NYSE:ACA (11/21/2025, 2:23:34 PM)
102.094
+2.68 (+2.7%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners95.34%
Inst Owner Change-4.39%
Ins Owners1.8%
Ins Owner Change-2.15%
Market Cap5.01B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target118.32 (15.89%)
Short Float %2.41%
Short Ratio5.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)0%
PT rev (3m)3.73%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-1.09%
EPS NY rev (1m)1.84%
EPS NY rev (3m)6.43%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.01 | ||
| Fwd PE | 21.74 | ||
| P/S | 1.77 | ||
| P/FCF | 15.91 | ||
| P/OCF | 10.67 | ||
| P/B | 1.94 | ||
| P/tB | 5.45 | ||
| EV/EBITDA | 12.06 |
EPS(TTM)3.78
EY3.7%
EPS(NY)4.7
Fwd EY4.6%
FCF(TTM)6.42
FCFY6.28%
OCF(TTM)9.57
OCFY9.37%
SpS57.77
BVpS52.71
TBVpS18.73
PEG (NY)0.75
PEG (5Y)5.23
Graham Number66.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.33 |
F-Score5
WACC9.8%
ROIC/WACC0.51
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year133.35%
EBIT Next 3Y37.6%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 6 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 27.01 and the Price/Book (PB) ratio is 1.94.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 36.06% in the next year.